Adoption and implementation of the original strict glycemic control guideline is feasible and safe in adult critically ill patients

Minerva Anestesiologica

Volumn 78, Issue 9, 2012, Pages 982-995

  Schultz, M J ^a,b   Harmsen, R E ^a   Korevaar, J C ^a   Abu Hanna, A ^a   van Braam Houckgeest, F ^c   Van Der Sluijs, J P ^d   Spronk, P E ^a,b,e  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b HERMES Critical Care Group   (Netherlands)

^c Tergooi Hospitals   (Netherlands)

^d MEDICAL CENTER HAAGLANDEN   (Netherlands)

^e GELRE HOSPITALS   (Netherlands)

Author keywords

Glucose; Health plan implementation; Insulin

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NURSE; PHYSICIAN; PRACTICE GUIDELINE;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CIRCADIAN RHYTHM; CRITICAL ILLNESS; FEMALE; GUIDELINE ADHERENCE; HOSPITAL MORTALITY; HOSPITALS, COMMUNITY; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NETHERLANDS; PRACTICE GUIDELINES AS TOPIC;

EID: 84866367347     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care 2009;13:R91.
2. Falciglia M, Freyberg RW, Almenoff PL, D'Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 2009;37:3001-9.
3. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003;290:2041-7.
4. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003;78:1471-8.
5. van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006:354:449-61.
6. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-67.
7. Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 2009;373:547-56.
8. Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008;36:3190-7.
9. de la Rosa GC, Donado JH, Restrepo AH, Quintero AM, Gonzalez LG, Saldarriaga NE, et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care 2008;12:R120.
10. Annane D, Cariou A, Maxime V, Azoulay E, D'Honneur G, Timsit JF et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 2010;303:341-8.
11. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39.
12. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-97.
13. Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009;35:1738-48.
14. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
15. Scurlock C, Raikhelkar J, Mechanick JI. Critique of normoglycemia in intensive care evaluation: survival using glucose algorithm regulation (NICE-SUGAR)--a review of recent literature. Curr Opin Clin Nutr Metab Care 2010;13:211-4.
16. Schultz MJ, Royakkers AA, Levi M, Moeniralam HS, Spronk PE. Intensive insulin therapy in intensive care: an example of the struggle to implement evidence-based medicine. PLoS Med 2006;3:e456.
17. Schultz MJ, Spronk PE, Afessa B, Gajic O. Evidence lost to treatment of critically-ill patients? Minerva Anestesiol 2009;75:715-29.
18. Schultz MJ, Spronk PE, van Braam Houckgeest F. Glucontrol, no control, or out of control? Intensive Care Med 2010;36:173-4 author reply 175-176.
19. Cook DJ, Montori VM, McMullin JP, Finfer SR, Rocker GM. Improving patients' safety locally: changing clinician behaviour. Lancet 2004;363:1224-30.
20. Grol R. Personal paper. Beliefs and evidence in changing clinical practice. BMJ 1997;315:418-21.
21. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet 2003;362:1225-30.
22. Schultz MJ, Harmsen RE, Spronk PE. Clinical review: Strict or loose glycemic control in critically ill patients-implementing best available evidence from randomized controlled trials. Crit Care 2010;14:223.
23. van den Berghe G, Schetz M, Vlasselaers D, Hermans G, Wilmer A, Bouillon R et al. Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab 2009;94:3163-70.
24. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007;35:2262-7.
25. Eslami S, de Keizer NF, de Jonge E, Schultz MJ, Abu-Hanna A. A systematic review on quality indicators for tight glycaemic control in critically ill patients: need for an unambiguous indicator reference subset. Crit Care 2008;12:R139.
26. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73.
27. Vogelzang M, van der Horst IC, Nijsten MW. Hyper-glycaemic index as a tool to assess glucose control: a retrospective study. Crit Care 2004;8:R122-7.
28. van Herpe T, De Brabanter J, Beullens M, De Moor B, van den Berghe G. Glycemic penalty index for adequately assessing and comparing different blood glucose control algorithms. Crit Care 2008;12:R24.
29. Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, van den Berghe G. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med 2010;38:1021-9.
30. Eslami S, Abu-Hanna A, de Keizer NF, Bosman RJ, Spronk PE, de Jonge E et al. Implementing glucose control in intensive care: a multicenter trial using statistical process control. Intensive Care Med 2010;36:1556-65.
31. Schultz MJ, Harsmen R, van der Sluijs JP, Spronk PE. Incidence of severe hypoglycemia with tight glycemic control: the higher the better? Acta Anaesthesiol Scand 2009;53:837-8; author reply 838-839.
32. Schultz MJ, van den Berghe G. Is "safe effective glucose control" effective and safe? Crit Care 2008;12:424;author reply 424.
33. Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 2007;117:910-8.
34. Vriesendorp TM, van Santen S, DeVries JH, de Jonge E, Rosendaal FR, Schultz MJ et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 2006;34:96-101.
35. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006;105:244-52.
36. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008;36:3008-13.
37. Egi M, Bellomo R, Reade MC. Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy? Crit Care 2009;13:302.
38. Vincent JL. Blood glucose control in 2010: 110 to 150 mg/dL and minimal variability. Crit Care Med 2010;38: 993-5.
39. Ceriello A, Ihnat MA, Thorpe JE. Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab 2009;94:410-5.
40. van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006;55:3151-9. ONLINE supplement.